Biotricity Statistics
Total Valuation
Biotricity has a market cap or net worth of 9.21 million. The enterprise value is 35.14 million.
| Market Cap | 9.21M |
| Enterprise Value | 35.14M |
Important Dates
The last earnings date was Friday, November 8, 2024.
| Earnings Date | Nov 8, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Biotricity has 23.02 million shares outstanding. The number of shares has increased by 18.86% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 23.02M |
| Shares Change (YoY) | +18.86% |
| Shares Change (QoQ) | +50.13% |
| Owned by Insiders (%) | 32.05% |
| Owned by Institutions (%) | 0.96% |
| Float | 15.03M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.34 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.92 |
| EV / Sales | 2.87 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.20
| Current Ratio | 0.20 |
| Quick Ratio | 0.11 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1.27 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -82.45% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | 222,624 |
| Profits Per Employee | -332,285 |
| Employee Count | 55 |
| Asset Turnover | 2.12 |
| Inventory Turnover | 1.67 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -48.16% in the last 52 weeks. The beta is 1.33, so Biotricity's price volatility has been higher than the market average.
| Beta (5Y) | 1.33 |
| 52-Week Price Change | -48.16% |
| 50-Day Moving Average | 0.33 |
| 200-Day Moving Average | 0.81 |
| Relative Strength Index (RSI) | 55.02 |
| Average Volume (20 Days) | 102,761 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 4.78 |
Income Statement
In the last 12 months, Biotricity had revenue of 12.24 million and -18.28 million in losses. Loss per share was -1.77.
| Revenue | 12.24M |
| Gross Profit | 8.80M |
| Operating Income | -7.63M |
| Pretax Income | -14.38M |
| Net Income | -18.28M |
| EBITDA | -7.62M |
| EBIT | -7.63M |
| Loss Per Share | -1.77 |
Balance Sheet
The company has 662,976 in cash and 23.09 million in debt, giving a net cash position of -22.42 million or -0.97 per share.
| Cash & Cash Equivalents | 662,976 |
| Total Debt | 23.09M |
| Net Cash | -22.42M |
| Net Cash Per Share | -0.97 |
| Equity (Book Value) | -26.27M |
| Book Value Per Share | -1.38 |
| Working Capital | -16.49M |
Cash Flow
| Operating Cash Flow | -6.36M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 71.89%, with operating and profit margins of -62.30% and -117.41%.
| Gross Margin | 71.89% |
| Operating Margin | -62.30% |
| Pretax Margin | -117.41% |
| Profit Margin | -117.41% |
| EBITDA Margin | -62.25% |
| EBIT Margin | -62.30% |
| FCF Margin | n/a |
Dividends & Yields
Biotricity does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -18.86% |
| Shareholder Yield | -18.86% |
| Earnings Yield | -441.61% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on July 3, 2023. It was a reverse split with a ratio of 0.1666667.
| Last Split Date | Jul 3, 2023 |
| Split Type | Reverse |
| Split Ratio | 0.1666667 |
Scores
Biotricity has an Altman Z-Score of -40.48. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -40.48 |
| Piotroski F-Score | n/a |